Literature DB >> 21656761

High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas.

Stefan S Bielack, Neyssa Marina, Mark Bernstein.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21656761     DOI： 10.1002/cncr.25881

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

Review 1.  MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.

Authors:  Alberto Bazzocchi; Alessandro Napoli; Beatrice Sacconi; Giuseppe Battista; Giuseppe Guglielmi; Carlo Catalano; Ugo Albisinni
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

2.  Neoadjuvant HIFU treatment for malignant fibrous histiocytoma: report of a case.

Authors:  Meiqi Zhou; Xiaoye Hu; Haifei He; Jiani Chen; Lirong Chen; Yongchuan Deng
Journal:  J Med Ultrason (2001)       Date:  2012-06-02       Impact factor: 1.314

3.  MRI-guided high-intensity focused ultrasound ablation of bone: evaluation of acute findings with MR and CT imaging in a swine model.

Authors:  Matthew D Bucknor; Viola Rieke; Loi Do; Sharmila Majumdar; Thomas M Link; Maythem Saeed
Journal:  J Magn Reson Imaging       Date:  2013-11-07       Impact factor: 4.813

4.  Extracorporeal ultrasound-guided high intensity focused ultrasound: implications from the present clinical trials.

Authors:  Tinghe Yu; Xiao Fu
Journal:  ScientificWorldJournal       Date:  2014-04-03

Review 5.  Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy.

Authors:  Yi-Hsuan Hsiao; Shou-Jen Kuo; Horng-Der Tsai; Ming-Chih Chou; Guang-Perng Yeh
Journal:  J Cancer       Date:  2016-01-03       Impact factor: 4.207

Review 6.  Current Status and Prospects of Clinical Treatment of Osteosarcoma.

Authors:  Zong-Yuan Jiang; Ji-Bin Liu; Xiao-Feng Wang; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.